Vote Scores
Filings read through

Spectrum Pharmaceuticals, Inc.: how funds voted at the meeting of 27 Jul 2023

Meeting
Season
year to 30 June 2024
Filers reporting
81
Ballot items
3

81 filers on Form N-PX reported votes at the Spectrum Pharmaceuticals, Inc. meeting of 27 Jul 2023. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Spectrum Pharmaceuticals, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Advisory vote on pay tied to a merger or sale

    95 vote records from 79 filers. 61 of the 74 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 21 fund families
    • Against 21
    • Against management 21
  2. Item 2: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    23 vote records from 17 filers. 0 of the 17 filers that marked the item voted against management.

    • Positions of 11 fund families
    • For 11
  3. Item 3: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    33 vote records from 20 filers. 2 of the 20 filers that marked the item voted against management.

    • Positions of 13 fund families
    • For 11
    • Against 2
    • Against management 2

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Spectrum Pharmaceuticals, Inc., meeting of 27 Jul 2023Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family1. Merger pay
BairdAgainst, against management
BlackRock and iSharesAgainst, against management
BNY MellonAgainst, against management
Charles SchwabAgainst, against management
Columbia ThreadneedleAgainst, against management
DimensionalAgainst, against management
FidelityAgainst, against management
Franklin TempletonAgainst, against management
Goldman SachsAgainst, against management
Guggenheim and RydexAgainst, against management
Jackson National fundsAgainst, against management
Janus HendersonAgainst, against management
John Hancock and ManulifeAgainst, against management
Lincoln FinancialAgainst, against management
Morgan Stanley, Eaton Vance and CalvertAgainst, against management
NationwideAgainst, against management
Northern Trust and FlexSharesAgainst, against management
PGIM and PrudentialAgainst, against management
State Street and SPDRAgainst, against management
VanguardAgainst, against management
Victory CapitalAgainst, against management

Questions

How many filers reported votes at the Spectrum Pharmaceuticals, Inc. meeting?
81 Form N-PX filers reported votes at the meeting of 27 Jul 2023.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Spectrum Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Spectrum Pharmaceuticals, Inc. with a meeting date within three days of 27 Jul 2023. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .